U.S. MarketsIMPORTANT
Thermo Fisher Scientific Inc. (TMO) Q3 2026 (USD): Adj. EPS 6.68 (exp. 6.40), Revenue 12.1bln (exp. 11.95bln), Adj. EBIT 2.97bln (exp. 2.86bln)
StockNow breaking-news AI analysis
Thermo Fisher Scientific’s Q3 2026 headline reported adjusted EPS, revenue, and adjusted EBIT above the expectations listed; the supplied item offers no further results context.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
